Segantii Capital Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,000,000
Closed -$24.7M 150
2023
Q3
$24.7M Buy
3,000,000
+500,000
+20% +$4.31M 0.87% 20
2023
Q2
$20M Hold
2,500,000
1.04% 25
2023
Q1
$20.3M Sell
2,500,000
-2,000,000
-44% -$16.1M 0.71% 32
2022
Q4
$28.3M Sell
4,500,000
-500,000
-10% -$3.49M 1.03% 22
2022
Q3
$34.5M Sell
5,000,000
-700,000
-12% -$4.86M 0.99% 24
2022
Q2
$47.7K Buy
5,700,000
+4,200,000
+280% +$58.7M 1.18% 23
2022
Q1
$34.3M Buy
1,500,000
+300,000
+25% +$7.33M 0.99% 24
2021
Q4
$33.1M Buy
1,200,000
+50,000
+4% +$1.34M 1.02% 21
2021
Q3
$32M Buy
1,150,000
+640,000
+125% +$18.1M 1.04% 16
2021
Q2
$15M Buy
+510,000
New +$15.5M 0.43% 61

Other funds holding BHC

Segantii Capital Management's BHC Position: Q4 2023 in Review

Segantii Capital Management sold out of Bausch Health (BHC) in Q4 2023, closing a stake of 3,000,000 shares — an estimated $24.7M sold.

Segantii Capital Management first reported a position in BHC in Q2 2021 and held it in 10 quarters. The position peaked at $34.5M in Q3 2022. 234 funds tracked by Wall St. Rank hold BHC as of Q4 2023.

  • Segantii Capital Management reported no remaining Bausch Health position as of Q4 2023 after selling out during the quarter.
  • Segantii Capital Management sold 3,000,000 Bausch Health shares in Q4 2023, an estimated $24.7M.
  • Segantii Capital Management first reported a position in Bausch Health in Q2 2021 and held it in 10 quarters.
  • Segantii Capital Management's Bausch Health position peaked at $34.5M in Q3 2022.
  • 234 funds tracked by Wall St. Rank held Bausch Health as of Q4 2023.

Based on Segantii Capital Management's 13F filing for Q4 2023, filed 7 Feb 2024.